Harbour Investments, Inc. Nektar Therapeutics Transaction History
Harbour Investments, Inc.
- $3.14 Billion
- Q3 2024
A detailed history of Harbour Investments, Inc. transactions in Nektar Therapeutics stock. As of the latest transaction made, Harbour Investments, Inc. holds 155 shares of NKTR stock, worth $215. This represents 0.0% of its overall portfolio holdings.
Number of Shares
155
Previous 155
-0.0%
Holding current value
$215
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding NKTR
# of Institutions
141Shares Held
134MCall Options Held
32.8KPut Options Held
55.5K-
Deep Track Capital, LP Greenwich, CT17.9MShares$24.8 Million0.73% of portfolio
-
Black Rock Inc. New York, NY15.2MShares$21.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13MShares$18 Million0.0% of portfolio
-
Samlyn Capital, LLC New York, NY9.46MShares$13.1 Million0.21% of portfolio
-
Eventide Asset Management, LLC Boston, MA7.53MShares$10.5 Million0.16% of portfolio
About NEKTAR THERAPEUTICS
- Ticker NKTR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,404,992
- Market Cap $260M
- Description
- Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...